8th Annual MS and Neuroimmunology Symposium
This accredited half-day symposium provides health care professionals information to identify, refer, treat and/or implement practice changes to improve the care of patients with neuroimmunological disorders. Specific disorders discussed this year include a 2 part update on Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy, stopping therapy in MS, Transverse myelitis, Anti-Amyloid Therapies, and managing fatigue.
Who should attend
Neurologists, neuroimmunologists, rheumatologists, ophthalmologists, neurosurgeons, physicians, nurse practitioners, rehabilitation including physical and occupational therapists, researchers, and other medical professionals in the field of neuroimmunological disorders are invited to attend.
Learning objectives
- Identify current diagnostic criteria and treatment updates for myasthenia gravis
- Recognize clinical features and apply updated management strategies for chronic inflammatory demyelinating polyneuropathy (CIDP)
- Evaluate appropriate criteria and timing for discontinuing disease-modifying therapies in multiple sclerosis patients
- Analyze case-based presentations of transverse myelitis to improve diagnostic accuracy and treatment decision-making
- Implement evidence-based strategies for managing fatigue in patients with multiple sclerosis
- Assess patient eligibility and monitoring requirements for anti-amyloid therapies in early-stage Alzheimer's disease
Agenda
8:30 a.m. Opening remarks
Chair and Moderator
Christopher Hollen, M.D.
Assistant Professor, Division of MS and Neuroimmunology
OHSU Department of Neurology
VA Portland Health Care System MS Center of Excellence West
Co-Chair
Vijayshree Yadav, M.B.B.S., M.C.R., FANA, FAAN
Interim Chair and Ann Middleton Foster Endowed Professorship for MS Research, Division of MS and Neuroimmunology
OHSU Department of Neurology
VA Portland Health Care System, MS Center of Excellence-West
8:45 a.m. Neuromuscular Part I: Myasthenia Gravis – Updates
Noona Leavell, M.D.
Assistant Professor, Section of Neuromuscular Medicine
OHSU Department of Neurology
9:15 a.m. Neuromuscular Part II: Chronic Inflammatory Demyelinating Polyneuropathy – Updates
Anson Wilks, M.D.
Assistant Professor, Section of Neuromuscular Medicine
OHSU Department of Neurology
9:45 a.m. When to stop therapy, discontinuing DMT in MS
Michelle Tsai, M.D.
2025 Postdoctoral Fellow, Division of MS and Neuroimmunology
OHSU Department of Neurology
VA Portland Health Care System MS Center of Excellence West
10:15 a.m. Transverse myelitis, a case-based discussion
Avinash Kolli, M.D.
2025 Postdoctoral Fellow, Division of MS and Neuroimmunology
OHSU Department of Neurology
VA Portland Health Care System MS Center of Excellence West
10:45 a.m. Break
11:00 a.m. Managing Fatigue in MS
Bardia Nourbakhsh, M.D., M.A.S.
Associate Program Director
Neuroimmunology and Neurological Infectious Disease Fellowship at Johns Hopkins School of Medicine
11:45 a.m. Anti-Amyloid Therapies for the Treatment of Early-Stage Alzheimer’s disease
Andrew Natonson, M.D., M.S.
Assistant Professor, Division of Aging, Alzheimer’s and Related Diseases
OHSU Department of Neurology
12:30 p.m. Closing remarks
Christopher Hollen, M.D.
OHSU Department of Neurology
VA Portland Health Care System MS Center of Excellence West
Registration
Registration fee for CME participants: $50
Registration fee waved for OHSU employees (resident, fellow, etc.) or VA employees
Online registration is required to participate live or to access recorded event.
October 11, 2025
8:30 a.m. – 12:30 p.m.
Virtual symposium
Link options for the 8th Annual MS and Neuroimmunology Symposium:
https://ohsu.webex.com/ohsu/j.php?MTID=m1a505dc9367d419706e49d481309bac4
In collaboration with:
VA MS Center of Excellence West, Portland VA Health Care System
October 11, 2025
8:30 a.m. – 12:30 p.m.
Virtual symposium
Link for the 8th Annual MS and Neuroimmunology Symposium
Contact
For questions, please contact Katlin Wozniak at wozniakka@ohsu.edu.